003020 立方製藥
按盤價 
26.870 +0.220 (+0.826%)
26.870 +0.220 (+0.826%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 6.839 | 9.382 | 14.322 | 15.033 | 13.901 |
| 總資產報酬率 ROA (%) | 4.666 | 6.336 | 9.844 | 11.025 | 10.729 |
| 投入資產回報率 ROIC (%) | 6.520 | 8.991 | 12.952 | 13.104 | 12.281 | 邊際利潤分析 |
| 銷售毛利率 (%) | 64.563 | 69.161 | 51.483 | 37.385 | 39.906 |
| 營業利潤率 (%) | 12.687 | 11.705 | 13.430 | 9.307 | 8.466 |
| 息稅前利潤/營業總收入 (%) | 12.698 | 11.300 | 13.369 | 9.160 | 8.500 |
| 淨利潤/營業總收入 (%) | 11.392 | 10.042 | 12.304 | 8.112 | 7.576 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 74.054 | 94.588 | 84.758 | 84.453 | 90.612 |
| 價值變動淨收益/利潤總額(%) | 20.251 | 7.568 | 10.800 | 13.449 | 5.761 |
| 營業外收支淨額/利潤總額(%) | -0.175 | -3.445 | 0.834 | -0.097 | 1.222 | 償債能力分析 |
| 流動比率 (X) | 2.210 | 2.037 | 2.121 | 2.333 | 3.718 |
| 速動比率 (X) | 1.708 | 1.658 | 1.673 | 1.752 | 3.142 |
| 資產負債率 (%) | 25.109 | 26.040 | 24.568 | 30.241 | 22.129 |
| 帶息債務/全部投入資本 (%) | 1.724 | 2.988 | 1.493 | 14.462 | 6.599 |
| 股東權益/帶息債務 (%) | 5,531.970 | 3,188.495 | 6,459.033 | 584.027 | 1,370.653 |
| 股東權益/負債合計 (%) | 275.810 | 258.085 | 276.234 | 230.675 | 351.900 |
| 利息保障倍數 (X) | 374.979 | -758.353 | -77.149 | -66.620 | -120.756 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 90.143 | 74.380 | 54.865 | 42.121 | 40.994 |
| 存貨周轉天數 (天) | 172.928 | 178.119 | 118.024 | 61.367 | 50.420 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 24/12/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
